v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating Activities    
Net income (loss) $ 89 $ 135
Adjustments to reconcile net income (loss) to net cash provided from (used by) operating activities:    
Depreciation and amortization 89 80
Non-cash stock-based compensation 35 34
Equity in net loss (income) of non-consolidated affiliates, net of dividends remitted (8) (5)
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 0 61
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item 2 (3)
Changes in assets and liabilities:    
Accounts receivable (91) 43
Inventories (94) (13)
Accounts payable 86 6
Other assets and other liabilities (27) (46)
Net cash provided from operating activities 81 292
Investing Activities    
Capital expenditures, including intangibles (103) (88)
Payments to Acquire Businesses, Net of Cash Acquired (20) (50)
Payments for (Proceeds from) Hedge, Investing Activities (11) 3
Other 0 (1)
Net cash used by investing activities (134) (136)
Financing Activities    
Proceeds from Issuance of Debt 2 0
Repayments of Lines of Credit (153) 0
Proceeds from Lines of Credit 179 0
Proceeds from Other Short-Term Debt 8 0
Payments of Ordinary Dividends, Noncontrolling Interest (9) (20)
Share repurchase (236) (7)
Payments of Ordinary Dividends, Common Stock (29) (8)
Payments Related to Tax Withholding for Share-based Compensation (9) (7)
Proceeds from Stock Options Exercised 8 3
Payment for Contingent Consideration Liability, Financing Activities (13) 0
Proceeds from (Payment for) Other Financing Activity (2) 0
Investment Company, Debt Instrument, Amount Repaid to Principal, Excess (Less) (7) (13)
Net cash used by financing activities (261) (52)
Effect of exchange rate changes on cash 7 35
Net increase (decrease) in cash, equivalents, and restricted cash (307) 139
Cash, equivalents, and restricted cash at beginning of the period 773 626
Cash, equivalents, and restricted cash at end of the period $ 466 $ 765